BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29747568)

  • 21. A methylation PCR method determines
    Hadd AG; Filipovic-Sadic S; Zhou L; Williams A; Latham GJ; Berry-Kravis E; Hall DA
    Clin Epigenetics; 2016; 8():130. PubMed ID: 27980694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
    Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
    Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation-specific PCR allows for fast diagnosis of X chromosome disomy and reveals skewed inactivation of the X chromosome in men with Klinefelter syndrome.
    Mehta A; Malek-Jones M; Bolyakov A; Mielnik A; Schlegel PN; Paduch DA
    J Androl; 2012; 33(5):955-62. PubMed ID: 22441764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
    Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
    PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Don't miss patients with atypical FMR1 mutations: dysmorphism and clinical features in a boy with a partially methylated FMR1 full mutation.
    Haberlandt E; Zotter S; Witsch-Baumgartner M; Zschocke J; Kotzot D
    Eur J Pediatr; 2014 Sep; 173(9):1257-61. PubMed ID: 25027833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of a novel Xp22.2 microdeletion as the cause of familial extreme skewing of X-inactivation utilizing case-parent trio SNP microarray analysis.
    Mason JA; Aung HT; Nandini A; Woods RG; Fairbairn DJ; Rowell JA; Young D; Susman RD; Brown SA; Hyland VJ; Robertson JD
    Mol Genet Genomic Med; 2018 May; 6(3):357-369. PubMed ID: 29490426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.
    Rajan-Babu IS; Lian M; Cheah FSH; Chen M; Tan ASC; Prasath EB; Loh SF; Chong SS
    Expert Rev Mol Med; 2017 Jul; 19():e10. PubMed ID: 28720156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
    Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
    J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of the absence of FMR1 expression in full mutation chorionic villi.
    Willemsen R; Bontekoe CJ; Severijnen LA; Oostra BA
    Hum Genet; 2002 Jun; 110(6):601-5. PubMed ID: 12107447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype.
    Collins SC; Coffee B; Benke PJ; Berry-Kravis E; Gilbert F; Oostra B; Halley D; Zwick ME; Cutler DJ; Warren ST
    PLoS One; 2010 Mar; 5(3):e9476. PubMed ID: 20221430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion in the FMR1 gene in a fragile-X male.
    Mannermaa A; Pulkkinen L; Kajanoja E; Ryynänen M; Saarikoski S
    Am J Med Genet; 1996 Aug; 64(2):293-5. PubMed ID: 8844068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assay for X inactivation based on differential methylation at the fragile X locus, FMR1.
    Carrel L; Willard HF
    Am J Med Genet; 1996 Jul; 64(1):27-30. PubMed ID: 8826444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germinal mosaicism for a deletion of the FMR1 gene leading to fragile X syndrome.
    Jiraanont P; Hagerman RJ; Neri G; Zollino M; Murdolo M; Tassone F
    Eur J Med Genet; 2016 Sep; 59(9):459-62. PubMed ID: 27546052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
    Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
    Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A deletion of 1.6 Kb proximal to the CGG repeat of the FMR1 gene causes fragile X-like psychological features.
    Wiegers AM; Curfs LM; Meijer H; Oostra B; Fryns JP
    Genet Couns; 1994; 5(4):377-80. PubMed ID: 7888141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragile X syndrome with FMR1 and FMR2 deletion.
    Moore SJ; Strain L; Cole GF; Miedzybrodzka Z; Kelly KF; Dean JC
    J Med Genet; 1999 Jul; 36(7):565-6. PubMed ID: 10424820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No apparent involvement of the FMR1 gene in five patients with phenotypic manifestations of the fragile X syndrome.
    Chiurazzi P; de Graaff E; Ng J; Verkerk AJ; Wolfson S; Fisch GS; Kozak L; Neri G; Oostra BA
    Am J Med Genet; 1994 Jul; 51(4):309-14. PubMed ID: 7942992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the 3'Epigenetic Boundary of the
    Godler DE; Inaba Y; Bui MQ; Francis D; Skinner C; Schwartz CE; Amor DJ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.